Iovino, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.881
EU - Europa 1.078
AS - Asia 970
AF - Africa 108
SA - Sud America 108
OC - Oceania 14
Totale 4.159
Nazione #
US - Stati Uniti d'America 1.786
IT - Italia 420
SG - Singapore 306
CN - Cina 292
SE - Svezia 215
HK - Hong Kong 126
FR - Francia 97
BR - Brasile 78
VN - Vietnam 72
BG - Bulgaria 68
DE - Germania 66
CI - Costa d'Avorio 54
GB - Regno Unito 53
CA - Canada 45
RU - Federazione Russa 30
JP - Giappone 27
FI - Finlandia 25
IN - India 24
QA - Qatar 18
LT - Lituania 15
NG - Nigeria 14
TR - Turchia 14
BE - Belgio 13
CR - Costa Rica 12
HN - Honduras 12
IQ - Iraq 12
SI - Slovenia 12
BD - Bangladesh 11
EE - Estonia 11
TH - Thailandia 11
MX - Messico 10
CY - Cipro 9
AR - Argentina 8
CG - Congo 8
EG - Egitto 8
PL - Polonia 8
VE - Venezuela 8
KR - Corea 7
NL - Olanda 7
PT - Portogallo 7
AU - Australia 6
ID - Indonesia 6
UA - Ucraina 6
UZ - Uzbekistan 6
AG - Antigua e Barbuda 5
CH - Svizzera 5
CL - Cile 5
KI - Kiribati 5
LC - Santa Lucia 5
MA - Marocco 5
MY - Malesia 5
PK - Pakistan 5
CO - Colombia 4
LV - Lettonia 4
AE - Emirati Arabi Uniti 3
AS - Samoa Americane 3
AT - Austria 3
ET - Etiopia 3
GA - Gabon 3
JO - Giordania 3
KE - Kenya 3
RO - Romania 3
ZA - Sudafrica 3
BJ - Benin 2
CZ - Repubblica Ceca 2
DM - Dominica 2
EC - Ecuador 2
ES - Italia 2
GR - Grecia 2
HU - Ungheria 2
PE - Perù 2
PH - Filippine 2
SA - Arabia Saudita 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
GT - Guatemala 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
MN - Mongolia 1
NI - Nicaragua 1
OM - Oman 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
Totale 4.159
Città #
Ashburn 208
Singapore 154
Chandler 138
San Jose 138
Woodbridge 131
Hong Kong 121
Santa Clara 120
Fairfield 117
Beijing 92
Dallas 84
Seattle 75
Houston 73
Sofia 64
Abidjan 54
Shanghai 52
Wilmington 52
New York 50
Serra 49
Milan 47
Ann Arbor 43
Boardman 42
Cambridge 41
Florence 30
Los Angeles 30
Princeton 29
Ottawa 27
Des Moines 26
London 25
Rome 24
Tokyo 24
Lawrence 23
Chicago 20
Medford 20
Lauterbourg 19
Ho Chi Minh City 18
Helsinki 16
Munich 16
Frankfurt am Main 15
Lagos 14
Chennai 13
Dong Ket 13
Council Bluffs 12
Hefei 12
Ljubljana 12
Brussels 11
Pisa 11
Redondo Beach 11
Tallinn 10
Bangkok 9
Bremen 9
Doha 9
Istanbul 9
San José 9
Toronto 9
Buffalo 8
Düsseldorf 8
Orem 8
Palermo 8
Changsha 7
Dearborn 7
Nanchang 7
Nanjing 7
Nicosia 7
Paris 7
San Diego 7
Stockholm 7
São Paulo 7
Bologna 6
Denver 6
Hebei 6
Phoenix 6
Seoul 6
Sydney 6
Tashkent 6
Turku 6
Brazzaville 5
Fuzhou 5
Jiaxing 5
Lisbon 5
Montreal 5
Nuremberg 5
Pietrasanta 5
Shenyang 5
St John's 5
Tarawa 5
Vilnius 5
Zurich 5
Arezzo 4
Atlanta 4
Boulder 4
Castries 4
Hanoi 4
Quanzhou 4
San Pedro Sula 4
Santiago 4
Addis Ababa 3
Amsterdam 3
Bari 3
Basingstoke 3
Bexley 3
Totale 2.730
Nome #
ROLE OF GENETIC POLYMORPHISMS ON RESPONSE TO R-CHOP REGIMEN IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 377
Manuale di Ematologia Quarta Edizione 351
R-CHOP21 VS R-CHOP14 IN 950 DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: RESULTS OF A MULTICENTRE RETROSPECTIVE STUDY FORM ITALIAN LYMPHOMA FOUNDATION (FIL) 252
The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia 250
Panobinostat for the treatment of acute myelogenous leukemia 208
The combination of rituximab and bendamustine as first-line treatment is highly effective in the eradicating minimal residual disease in follicular lymphoma: An Italian retrospective study 198
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT 183
Clinical use of an immune monitoring panel in liver transplant recipients: A prospective, observational study. 173
Immune Reconstitution after Allogeneic Stem Cell Transplantation: a Pilot Flow-Cytometry Study for T-Cell Sub-Populations 171
ACUTE T-LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC T-CELL LYMPHOMA. ROLE OF EARLY allo-SCT 166
The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice 163
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia 161
ZINC ORAL SUPPLEMENTATION INDUCES A SIGNIFICANT RISE OF TRECS AND T CD4+ NAΪVE AND PREVENTS THE INCREASE OF TTV VIRAL LOAD AFTER STEM CELL TRANSPLANTATION: THE ZENITH STUDY 158
The Onset of Monoclonal and Oligoclonal Gammopathies Is a Good Prognostic Factor after Allogeneic Stem Cell Transplantation 157
The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients 156
The onset of monoclonal and oligoclonal gammopathies is a good prognostic factor after allogeneic stem cell transplantation 151
FIRST LINE TREATMENT WITH BENDAMUSTINE IN SELECTED NON HODGKIN'S LYMPHOMA PATIENTS: PROSPECTIVE EXPERIENCE IN TUSCANY REGION 141
AUTOLOGOUS-STEM CELL TRANSPLANTATION IN DIFFUSE-LARGE B CELL LYMPHOMA: THE TUSCANY EXPERIENCE 140
IMPACT OF DOSE-DENSE IMMUNOCHEMOTHERAPY ON PROGNOSIS OF GERMINAL CENTER AND NON GERMINAL CENTER ORIGIN OF DIFFUSE LARGE B CELL LYMPHOMA 137
Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia 135
Cytokine Release from Stimulated PBMC after-HSCT: Results of a Post-Transplant Zinc Oral Supplementation Trial (ZENITH). 129
AUTOLOGOUS-STEM CELL TRANSPLANTATION IN HODGKIN'S LYMPHOMA: THE TUSCANY EXPERIENCE 129
Mini-Allogeneic Transplantation in Multiple Myeloma: A Single-Center Ten-Year Experience 119
Totale 4.205
Categoria #
all - tutte 11.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 0 49
2021/2022336 9 13 5 16 56 46 18 12 39 11 27 84
2022/2023515 76 104 28 23 54 48 10 47 74 4 39 8
2023/2024237 19 17 34 16 32 43 15 7 0 10 5 39
2024/2025828 8 26 15 54 101 81 67 35 97 102 75 167
2025/20261.241 71 107 77 91 179 68 136 40 66 311 85 10
Totale 4.205